402 related articles for article (PubMed ID: 9649504)
21. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
[TBL] [Abstract][Full Text] [Related]
22. Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers.
Zheng ZM; He PJ; Baker CC
J Virol; 1997 Dec; 71(12):9096-107. PubMed ID: 9371566
[TBL] [Abstract][Full Text] [Related]
23. Sequence-specific RNA binding by an SR protein requires RS domain phosphorylation: creation of an SRp40-specific splicing enhancer.
Tacke R; Chen Y; Manley JL
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1148-53. PubMed ID: 9037021
[TBL] [Abstract][Full Text] [Related]
24. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
Chung H ; Derse D
J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
[TBL] [Abstract][Full Text] [Related]
25. Alternative splicing of the adenylyl cyclase stimulatory G-protein G alpha(s) is regulated by SF2/ASF and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and involves the use of an unusual TG 3'-splice Site.
Pollard AJ; Krainer AR; Robson SC; Europe-Finner GN
J Biol Chem; 2002 May; 277(18):15241-51. PubMed ID: 11825891
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with a purine-rich exonic splicing enhancer sequence in Xenopus oocyte nucleus.
Masuyama K; Taniguchi I; Okawa K; Ohno M
Biochem Biophys Res Commun; 2007 Aug; 359(3):580-5. PubMed ID: 17548051
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide analysis reveals SR protein cooperation and competition in regulated splicing.
Pandit S; Zhou Y; Shiue L; Coutinho-Mansfield G; Li H; Qiu J; Huang J; Yeo GW; Ares M; Fu XD
Mol Cell; 2013 Apr; 50(2):223-35. PubMed ID: 23562324
[TBL] [Abstract][Full Text] [Related]
28. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
[TBL] [Abstract][Full Text] [Related]
29. Purifying Selection on Exonic Splice Enhancers in Intronless Genes.
Savisaar R; Hurst LD
Mol Biol Evol; 2016 Jun; 33(6):1396-418. PubMed ID: 26802218
[TBL] [Abstract][Full Text] [Related]
30. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.
Zhu J; Mayeda A; Krainer AR
Mol Cell; 2001 Dec; 8(6):1351-61. PubMed ID: 11779509
[TBL] [Abstract][Full Text] [Related]
31. Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs).
Gorlov IP; Gorlova OY; Frazier ML; Amos CI
Mutat Res; 2004 Oct; 554(1-2):175-83. PubMed ID: 15450416
[TBL] [Abstract][Full Text] [Related]
32. Subtle discrepancies of SF2/ASF ESE sequence motif among human tissues: A computational approach.
Siala O; Rebai A; Baklouti F; Fakhfakh F
Comput Biol Chem; 2010 Jun; 34(3):203-9. PubMed ID: 20637698
[TBL] [Abstract][Full Text] [Related]
33. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases.
Blencowe BJ
Trends Biochem Sci; 2000 Mar; 25(3):106-10. PubMed ID: 10694877
[TBL] [Abstract][Full Text] [Related]
34. PLP1 alternative splicing in differentiating oligodendrocytes: characterization of an exonic splicing enhancer.
Wang E; Huang Z; Hobson GM; Dimova N; Sperle K; McCullough A; Cambi F
J Cell Biochem; 2006 Apr; 97(5):999-1016. PubMed ID: 16288477
[TBL] [Abstract][Full Text] [Related]
35. Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.
Bourgeois CF; Popielarz M; Hildwein G; Stevenin J
Mol Cell Biol; 1999 Nov; 19(11):7347-56. PubMed ID: 10523623
[TBL] [Abstract][Full Text] [Related]
36. Automatic detection of exonic splicing enhancers (ESEs) using SVMs.
Mersch B; Gepperth A; Suhai S; Hotz-Wagenblatt A
BMC Bioinformatics; 2008 Sep; 9():369. PubMed ID: 18783607
[TBL] [Abstract][Full Text] [Related]
37. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
Dauksaite V; Akusjärvi G
Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
[TBL] [Abstract][Full Text] [Related]
38. Evidence for deep phylogenetic conservation of exonic splice-related constraints: splice-related skews at exonic ends in the brown alga Ectocarpus are common and resemble those seen in humans.
Wu X; Tronholm A; Cáceres EF; Tovar-Corona JM; Chen L; Urrutia AO; Hurst LD
Genome Biol Evol; 2013; 5(9):1731-45. PubMed ID: 23902749
[TBL] [Abstract][Full Text] [Related]
39. The deep intronic c.903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria.
Homolova K; Zavadakova P; Doktor TK; Schroeder LD; Kozich V; Andresen BS
Hum Mutat; 2010 Apr; 31(4):437-44. PubMed ID: 20120036
[TBL] [Abstract][Full Text] [Related]
40. Factors involved in the activation of pre-mRNA splicing from downstream splicing enhancers.
Achsel T; Shimura Y
J Biochem; 1996 Jul; 120(1):53-60. PubMed ID: 8864844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
